"ProtocolName","LabelName","GroupValues","Size","Estimator","ROC_AUC","Direction","Threshold","Accuracy","Precision","Recall"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile Bernoulli NB classification","0.8263941940412529","UP","7.531809262913981","0.5847953216374269","0.19318181818181818","1.0"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF on folded fp classification","0.8252482811306341","UP","7.531809262913981","0.847953216374269","0.15384615384615385","0.11764705882352941"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF classification","0.8086325439266616","UP","7.531809262913981","0.8654970760233918","0.2","0.11764705882352941"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.7605042016806726","UP","7.531809262913981","0.8596491228070176","0.0","0.0"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile SVC RBF classification","0.6883116883116885","UP","7.531809262913981","0.8771929824561403","0.16666666666666666","0.058823529411764705"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile SVC Poly classification","0.619556913674561","UP","7.531809262913981","0.9005847953216374","NaN","0.0"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF on folded fp classification","0.8891613684529217","UP","8.522878745280337","0.912621359223301","0.6666666666666666","0.4"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile SVC Poly classification","0.8754465637299419","UP","8.522878745280337","0.8907766990291263","NaN","0.0"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF classification","0.8753860127157131","UP","8.522878745280337","0.8980582524271845","0.5714285714285714","0.26666666666666666"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile Bernoulli NB classification","0.853587647593097","UP","8.522878745280337","0.6067961165048543","0.2146341463414634","0.9777777777777777"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile SVC Tanimoto classification","0.8530426884650338","UP","8.522878745280337","0.9077669902912622","0.6842105263157895","0.28888888888888886"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile SVC RBF classification","0.8526793823796505","UP","8.522878745280337","0.9004854368932039","0.6111111111111112","0.24444444444444444"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF on folded fp classification","0.711826857532379","UP","7.785649512854599","0.8784530386740331","0.0","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF classification","0.7046693933197001","UP","7.785649512854599","0.8895027624309392","0.3333333333333333","0.1111111111111111"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile Bernoulli NB classification","0.6492842535787321","UP","7.785649512854599","0.5303867403314917","0.14736842105263157","0.7777777777777778"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile SVC RBF classification","0.6455351056578049","UP","7.785649512854599","0.9005524861878453","NaN","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile SVC Tanimoto classification","0.6095773687798224","UP","7.785649512854599","0.9005524861878453","NaN","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile SVC Poly classification","0.608214042263122","UP","7.785649512854599","0.9005524861878453","NaN","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF on folded fp classification","0.9258893280632411","UP","7.638272163982407","0.8932038834951457","0.5","0.2727272727272727"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile Bernoulli NB classification","0.924407114624506","UP","7.638272163982407","0.5922330097087378","0.20754716981132076","1.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF classification","0.891304347826087","UP","7.638272163982407","0.8737864077669902","0.0","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile SVC Poly classification","0.8483201581027671","UP","7.638272163982407","0.8932038834951457","NaN","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.8453557312252966","UP","7.638272163982407","0.8932038834951457","NaN","0.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile SVC RBF classification","0.6808300395256918","UP","7.638272163982407","0.883495145631068","0.0","0.0"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile SVC Tanimoto classification","0.8768278965129361","UP","6.574707347221943","0.900709219858156","NaN","0.0"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile SVC Poly classification","0.8593925759280086","UP","6.574707347221943","0.900709219858156","NaN","0.0"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF classification","0.8225534308211474","UP","6.574707347221943","0.8936170212765957","0.4","0.14285714285714285"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile Bernoulli NB classification","0.8205849268841395","UP","6.574707347221943","0.6382978723404256","0.20634920634920634","0.9285714285714286"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF on folded fp classification","0.7736220472440944","UP","6.574707347221943","0.8936170212765957","0.42857142857142855","0.21428571428571427"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile SVC RBF classification","0.5928008998875155","UP","6.574707347221943","0.900709219858156","0.5","0.07142857142857142"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF classification","0.8381651376146788","UP","8.154901959985743","0.9218106995884774","0.75","0.36"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile SVC RBF classification","0.8185321100917446","UP","8.154901959985743","0.9259259259259259","1.0","0.28"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF on folded fp classification","0.7577064220183486","UP","8.154901959985743","0.9053497942386831","0.625","0.2"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile SVC Tanimoto classification","0.7370642201834857","UP","8.154901959985743","0.897119341563786","0.5","0.04"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile SVC Poly classification","0.7256880733944947","UP","8.154901959985743","0.897119341563786","NaN","0.0"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile Bernoulli NB classification","0.6691743119266046","UP","8.154901959985743","0.4609053497942387","0.13194444444444445","0.76"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF on folded fp classification","0.8893534649632214","UP","8.397940008672037","0.901685393258427","0.65","0.3170731707317073"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile SVC Tanimoto classification","0.8871080139372808","UP","8.397940008672037","0.8904494382022472","0.5833333333333334","0.17073170731707318"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile SVC Poly classification","0.8765001935733648","UP","8.397940008672037","0.9129213483146067","1.0","0.24390243902439024"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile Bernoulli NB classification","0.8271002710027118","UP","8.397940008672037","0.48314606741573035","0.1735159817351598","0.926829268292683"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF classification","0.7735965931087883","UP","8.397940008672037","0.8792134831460674","0.4642857142857143","0.3170731707317073"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile SVC RBF classification","0.6790166473093295","UP","8.397940008672037","0.8876404494382022","0.5454545454545454","0.14634146341463414"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF on folded fp classification","0.8130126771066368","UP","7.284832642151542","0.8562874251497006","0.0","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile SVC Poly classification","0.7796420581655468","UP","7.284832642151542","0.8922155688622755","NaN","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile SVC Tanimoto classification","0.7572706935123039","UP","7.284832642151542","0.8922155688622755","NaN","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile Bernoulli NB classification","0.7483221476510069","UP","7.284832642151542","0.6526946107784432","0.2222222222222222","0.8888888888888888"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF classification","0.7240865026099925","UP","7.284832642151542","0.844311377245509","0.0","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile SVC RBF classification","0.521252796420582","UP","7.284832642151542","0.8802395209580839","0.0","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile SVC Tanimoto classification","0.918440428380185","UP","5.650004100737144","0.9175627240143369","0.6944444444444444","0.4166666666666667"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile SVC Poly classification","0.9095381526104424","UP","5.650004100737144","0.8924731182795699","NaN","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF on folded fp classification","0.8885876840696121","UP","5.650004100737144","0.9354838709677419","0.8333333333333334","0.5"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile Bernoulli NB classification","0.8727409638554188","UP","5.650004100737144","0.7078853046594982","0.2559241706161137","0.9"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF classification","0.792938420348059","UP","5.650004100737144","0.8853046594982079","0.35714285714285715","0.08333333333333333"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile SVC RBF classification","0.7044511378848732","UP","5.650004100737144","0.8870967741935484","0.2","0.016666666666666666"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile SVC Poly classification","0.9233648191053303","UP","5.599997654072045","0.8975206611570248","NaN","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile SVC Tanimoto classification","0.922919265728036","UP","5.599997654072045","0.9223140495867769","0.7586206896551724","0.3548387096774194"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF on folded fp classification","0.915151785183866","UP","5.599997654072045","0.9355371900826446","0.7674418604651163","0.532258064516129"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile Bernoulli NB classification","0.8947008851660438","UP","5.599997654072045","0.7504132231404959","0.27638190954773867","0.8870967741935484"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF classification","0.8143676112398266","UP","5.599997654072045","0.8958677685950414","0.45454545454545453","0.08064516129032258"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile SVC RBF classification","0.7943028574823275","UP","5.599997654072045","0.8942148760330578","0.3333333333333333","0.03225806451612903"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile SVC Tanimoto classification","0.9128995802389407","UP","6.250031916490597","0.9120879120879121","0.75","0.23684210526315788"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile SVC Poly classification","0.910154988698739","UP","6.250031916490597","0.8956043956043956","NaN","0.0"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF on folded fp classification","0.8839602841459478","UP","6.250031916490597","0.9395604395604396","0.8333333333333334","0.5263157894736842"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile Bernoulli NB classification","0.8651113981272189","UP","6.250031916490597","0.6483516483516484","0.21875","0.9210526315789473"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF classification","0.7902405553761704","UP","6.250031916490597","0.8956043956043956","0.5","0.07894736842105263"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile SVC RBF classification","0.6561995479496288","UP","6.250031916490597","0.8928571428571429","0.0","0.0"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF on folded fp classification","0.8802447552447552","UP","6.490843860609926","0.9130434782608695","1.0","0.09090909090909091"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile SVC Tanimoto classification","0.8321678321678323","UP","6.490843860609926","0.9304347826086956","1.0","0.2727272727272727"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile SVC Poly classification","0.8173076923076922","UP","6.490843860609926","0.9043478260869565","NaN","0.0"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF classification","0.7596153846153846","UP","6.490843860609926","0.8956521739130435","0.42857142857142855","0.2727272727272727"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile Bernoulli NB classification","0.7128496503496502","UP","6.490843860609926","0.6695652173913044","0.13513513513513514","0.45454545454545453"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile SVC RBF classification","0.6433566433566433","UP","6.490843860609926","0.8869565217391304","0.0","0.0"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF classification","0.7676107480029049","UP","8.0","0.8888888888888888","0.46153846153846156","0.3333333333333333"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF on folded fp classification","0.7552650689905592","UP","8.0","0.8947368421052632","0.5","0.2222222222222222"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.7509077705156133","UP","8.0","0.8888888888888888","0.0","0.0"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile Bernoulli NB classification","0.7345679012345677","UP","8.0","0.5263157894736842","0.16842105263157894","0.8888888888888888"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile SVC Poly classification","0.7153231663035586","UP","8.0","0.8947368421052632","NaN","0.0"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile SVC RBF classification","0.7124183006535945","UP","8.0","0.9181286549707602","0.8333333333333334","0.2777777777777778"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF on folded fp classification","0.8477827050997784","UP","8.469321313575849","0.9251101321585903","0.6470588235294118","0.5"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile Bernoulli NB classification","0.8033259423503311","UP","8.469321313575849","0.5594713656387665","0.1694915254237288","0.9090909090909091"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile SVC Tanimoto classification","0.7952328159645222","UP","8.469321313575849","0.9074889867841409","0.6666666666666666","0.09090909090909091"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF classification","0.7830376940133038","UP","8.469321313575849","0.8942731277533039","0.4375","0.3181818181818182"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile SVC Poly classification","0.7570953436807075","UP","8.469321313575849","0.9030837004405287","NaN","0.0"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile SVC RBF classification","0.695565410199556","UP","8.469321313575849","0.920704845814978","0.75","0.2727272727272727"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF classification","0.7859907120743034","UP","7.180456064458131","0.9112426035502958","0.6","0.35294117647058826"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF on folded fp classification","0.7811532507739936","UP","7.180456064458131","0.8757396449704142","0.3","0.17647058823529413"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile Bernoulli NB classification","0.7498065015479873","UP","7.180456064458131","0.5207100591715976","0.1595744680851064","0.8823529411764706"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile SVC RBF classification","0.6865325077399373","UP","7.180456064458131","0.893491124260355","0.0","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile SVC Tanimoto classification","0.6797600619195039","UP","7.180456064458131","0.8994082840236687","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile SVC Poly classification","0.6669891640866866","UP","7.180456064458131","0.8994082840236687","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile SVC Poly classification","0.8743872549019629","UP","8.3767507096021","0.8942917547568711","0.3333333333333333","0.041666666666666664"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF on folded fp classification","0.8732107843137249","UP","8.3767507096021","0.9175475687103594","0.6451612903225806","0.4166666666666667"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile Bernoulli NB classification","0.8650245098039209","UP","8.3767507096021","0.6807610993657506","0.2275132275132275","0.8958333333333334"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF classification","0.8556372549019609","UP","8.3767507096021","0.919661733615222","0.7272727272727273","0.3333333333333333"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile SVC Tanimoto classification","0.8479656862745121","UP","8.3767507096021","0.8964059196617337","0.47368421052631576","0.1875"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile SVC RBF classification","0.7922549019607847","UP","8.3767507096021","0.9133192389006343","0.6666666666666666","0.2916666666666667"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF on folded fp classification","0.9590886618325642","UP","9.0","0.936986301369863","0.6842105263157895","0.7027027027027027"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile SVC Tanimoto classification","0.9453279499011202","UP","9.0","0.915068493150685","0.59375","0.5135135135135135"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile Bernoulli NB classification","0.929960448253131","UP","9.0","0.8767123287671232","0.44594594594594594","0.8918918918918919"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile SVC Poly classification","0.9202785102175345","UP","9.0","0.9013698630136986","0.52","0.35135135135135137"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF classification","0.9114617666446936","UP","9.0","0.9397260273972603","0.7272727272727273","0.6486486486486487"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile SVC RBF classification","0.8492089650626236","UP","9.0","0.9205479452054794","0.6818181818181818","0.40540540540540543"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile SVC Poly classification","0.9324692234848547","UP","8.154901959985743","0.897196261682243","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF on folded fp classification","0.9175248579545459","UP","8.154901959985743","0.9299065420560748","0.8181818181818182","0.4090909090909091"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile SVC Tanimoto classification","0.8961884469697022","UP","8.154901959985743","0.9065420560747663","0.6666666666666666","0.18181818181818182"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile Bernoulli NB classification","0.8732836174242419","UP","8.154901959985743","0.6214953271028038","0.205","0.9318181818181818"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF classification","0.8596709280303031","UP","8.154901959985743","0.9182242990654206","0.7368421052631579","0.3181818181818182"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile SVC RBF classification","0.8280066287878797","UP","8.154901959985743","0.927570093457944","0.8095238095238095","0.38636363636363635"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF on folded fp classification","0.8815544608648053","UP","8.144396149730508","0.9135254988913526","0.625","0.3333333333333333"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile SVC Poly classification","0.853557744937054","UP","8.144396149730508","0.9002217294900222","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile SVC Tanimoto classification","0.8425013683634355","UP","8.144396149730508","0.9113082039911308","0.6470588235294118","0.24444444444444444"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile Bernoulli NB classification","0.8218390804597692","UP","8.144396149730508","0.6053215077605322","0.19069767441860466","0.9111111111111111"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF classification","0.8023809523809523","UP","8.144396149730508","0.8980044345898004","0.48","0.26666666666666666"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile SVC RBF classification","0.7902572523262168","UP","8.144396149730508","0.9024390243902439","0.5384615384615384","0.15555555555555556"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF classification","0.9023210831721471","UP","9.154901959985743","0.8666666666666667","0.36363636363636365","0.36363636363636365"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile Bernoulli NB classification","0.8829787234042553","UP","9.154901959985743","0.7428571428571429","0.2894736842105263","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile SVC Tanimoto classification","0.8621856866537718","UP","9.154901959985743","0.8952380952380953","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF on folded fp classification","0.8505802707930368","UP","9.154901959985743","0.8476190476190476","0.14285714285714285","0.09090909090909091"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile SVC Poly classification","0.7935203094777564","UP","9.154901959985743","0.8952380952380953","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile SVC RBF classification","0.6353965183752415","UP","9.154901959985743","0.8476190476190476","0.2222222222222222","0.18181818181818182"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF classification","0.9023210831721471","UP","9.154901959985743","0.8666666666666667","0.36363636363636365","0.36363636363636365"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile Bernoulli NB classification","0.8829787234042553","UP","9.154901959985743","0.7428571428571429","0.2894736842105263","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile SVC Tanimoto classification","0.8650870406189555","UP","9.154901959985743","0.8952380952380953","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF on folded fp classification","0.8505802707930368","UP","9.154901959985743","0.8476190476190476","0.14285714285714285","0.09090909090909091"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile SVC Poly classification","0.794487427466151","UP","9.154901959985743","0.8952380952380953","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile SVC RBF classification","0.6353965183752415","UP","9.154901959985743","0.8476190476190476","0.2222222222222222","0.18181818181818182"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF on folded fp classification","0.8875","UP","8.752045101616314","0.8962264150943396","0.42857142857142855","0.3"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile Bernoulli NB classification","0.8687500000000001","UP","8.752045101616314","0.6415094339622641","0.1956521739130435","0.9"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF classification","0.8651041666666667","UP","8.752045101616314","0.8773584905660378","0.2857142857142857","0.2"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile SVC Tanimoto classification","0.8427083333333334","UP","8.752045101616314","0.9056603773584906","NaN","0.0"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile SVC Poly classification","0.804166666666667","UP","8.752045101616314","0.9056603773584906","NaN","0.0"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile SVC RBF classification","0.6999999999999998","UP","8.752045101616314","0.8962264150943396","0.0","0.0"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile Bernoulli NB classification","0.7706521739130431","UP","8.522878745280337","0.6","0.25","0.85"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF on folded fp classification","0.7386956521739132","UP","8.522878745280337","0.8518518518518519","0.5","0.35"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile SVC Tanimoto classification","0.7108695652173904","UP","8.522878745280337","0.837037037037037","0.0","0.0"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF classification","0.6902173913043478","UP","8.522878745280337","0.8148148148148148","0.2727272727272727","0.15"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile SVC RBF classification","0.6765217391304342","UP","8.522878745280337","0.8518518518518519","0.5","0.05"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile SVC Poly classification","0.6482608695652173","UP","8.522878745280337","0.8518518518518519","NaN","0.0"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF on folded fp classification","0.8880974264705883","UP","8.823908740944319","0.875","0.36363636363636365","0.25"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF classification","0.8704044117647058","UP","8.823908740944319","0.8881578947368421","0.4","0.125"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile Bernoulli NB classification","0.8242187499999999","UP","8.823908740944319","0.46710526315789475","0.16494845360824742","1.0"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile SVC Poly classification","0.8157169117647058","UP","8.823908740944319","0.8947368421052632","NaN","0.0"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile SVC Tanimoto classification","0.7922794117647055","UP","8.823908740944319","0.8947368421052632","NaN","0.0"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile SVC RBF classification","0.7536764705882348","UP","8.823908740944319","0.9078947368421053","1.0","0.125"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF on folded fp classification","0.7529452529452529","UP","6.730487055782083","0.8790322580645161","0.25","0.07692307692307693"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile SVC Tanimoto classification","0.7491337491337493","UP","6.730487055782083","0.8870967741935484","0.0","0.0"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile SVC Poly classification","0.7491337491337486","UP","6.730487055782083","0.8951612903225806","NaN","0.0"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile SVC RBF classification","0.7269577269577268","UP","6.730487055782083","0.8951612903225806","NaN","0.0"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF classification","0.6583506583506583","UP","6.730487055782083","0.8870967741935484","0.0","0.0"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile Bernoulli NB classification","0.6472626472626473","UP","6.730487055782083","0.5806451612903226","0.15789473684210525","0.6923076923076923"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF on folded fp classification","0.825684024713151","UP","5.679759281514789","0.9035087719298246","0.5","0.09090909090909091"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile Bernoulli NB classification","0.7894969108561344","UP","5.679759281514789","0.4649122807017544","0.14285714285714285","0.9090909090909091"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF classification","0.7533097969991174","UP","5.679759281514789","0.9035087719298246","0.5","0.09090909090909091"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile SVC Tanimoto classification","0.7250661959399826","UP","5.679759281514789","0.9210526315789473","1.0","0.18181818181818182"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile SVC Poly classification","0.6341571050308916","UP","5.679759281514789","0.9035087719298246","NaN","0.0"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile SVC RBF classification","0.6028243601059136","UP","5.679759281514789","0.8947368421052632","0.0","0.0"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile SVC Poly classification","0.9899475524475524","UP","7.423990434433298","0.9130434782608695","1.0","0.09090909090909091"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile SVC Tanimoto classification","0.9890734265734266","UP","7.423990434433298","0.9652173913043478","0.8888888888888888","0.7272727272727273"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF on folded fp classification","0.9881993006993007","UP","7.423990434433298","0.9652173913043478","0.8888888888888888","0.7272727272727273"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile Bernoulli NB classification","0.965034965034965","UP","7.423990434433298","0.8521739130434782","0.39285714285714285","1.0"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF classification","0.9138986013986015","UP","7.423990434433298","0.9391304347826087","0.8333333333333334","0.45454545454545453"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile SVC RBF classification","0.8365384615384615","UP","7.423990434433298","0.9130434782608695","0.6666666666666666","0.18181818181818182"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile Bernoulli NB classification","0.8485603543743078","UP","7.605883915784709","0.5454545454545454","0.17721518987341772","1.0"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF on folded fp classification","0.8006644518272426","UP","7.605883915784709","0.8811188811188811","0.3333333333333333","0.21428571428571427"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile SVC Tanimoto classification","0.7563676633444079","UP","7.605883915784709","0.8951048951048951","0.0","0.0"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF classification","0.7259136212624584","UP","7.605883915784709","0.8741258741258742","0.16666666666666666","0.07142857142857142"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile SVC Poly classification","0.7109634551495018","UP","7.605883915784709","0.9020979020979021","NaN","0.0"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile SVC RBF classification","0.5852713178294576","UP","7.605883915784709","0.8881118881118881","0.0","0.0"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF classification","0.9471747388414052","UP","7.886056647693163","0.9242424242424242","0.9782608695652174","0.8333333333333334"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile SVC RBF classification","0.9388651471984808","UP","7.886056647693163","0.8787878787878788","0.975","0.7222222222222222"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile Bernoulli NB classification","0.9376780626780621","UP","7.886056647693163","0.9090909090909091","0.875","0.9074074074074074"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF on folded fp classification","0.9374406457739791","UP","7.886056647693163","0.9318181818181818","0.9591836734693877","0.8703703703703703"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile SVC Poly classification","0.9339981006647667","UP","7.886056647693163","0.9242424242424242","0.9782608695652174","0.8333333333333334"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile SVC Tanimoto classification","0.927825261158595","UP","7.886056647693163","0.9318181818181818","0.9591836734693877","0.8703703703703703"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile SVC Poly classification","0.9501557632398754","UP","8.823908740944319","0.8991596638655462","NaN","0.0"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF on folded fp classification","0.9384735202492211","UP","8.823908740944319","0.9159663865546218","0.625","0.4166666666666667"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile SVC Tanimoto classification","0.9353582554517135","UP","8.823908740944319","0.8991596638655462","NaN","0.0"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile Bernoulli NB classification","0.8975856697819315","UP","8.823908740944319","0.6050420168067226","0.2033898305084746","1.0"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF classification","0.6884735202492211","UP","8.823908740944319","0.865546218487395","0.25","0.16666666666666666"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile SVC RBF classification","0.6292834890965732","UP","8.823908740944319","0.8739495798319328","0.0","0.0"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF on folded fp classification","0.9037763253449527","UP","7.585026652029182","0.9298245614035088","0.75","0.5"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile Bernoulli NB classification","0.8578431372549018","UP","7.585026652029182","0.5789473684210527","0.18604651162790697","0.8888888888888888"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF classification","0.8489469862018881","UP","7.585026652029182","0.9122807017543859","0.7142857142857143","0.2777777777777778"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile SVC Poly classification","0.8304284676833695","UP","7.585026652029182","0.8947368421052632","NaN","0.0"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.8097312999273784","UP","7.585026652029182","0.9005847953216374","1.0","0.05555555555555555"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile SVC RBF classification","0.6724763979665942","UP","7.585026652029182","0.9064327485380117","1.0","0.1111111111111111"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile Bernoulli NB classification","0.9081027667984191","UP","7.721246399047171","0.6699029126213593","0.23255813953488372","0.9090909090909091"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF on folded fp classification","0.8913043478260869","UP","7.721246399047171","0.8932038834951457","0.5","0.36363636363636365"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile SVC Poly classification","0.8883399209486166","UP","7.721246399047171","0.8932038834951457","NaN","0.0"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF classification","0.882905138339921","UP","7.721246399047171","0.883495145631068","0.4","0.18181818181818182"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.874505928853755","UP","7.721246399047171","0.883495145631068","0.3333333333333333","0.09090909090909091"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile SVC RBF classification","0.7134387351778657","UP","7.721246399047171","0.8932038834951457","NaN","0.0"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF classification","0.6351403306420607","UP","6.561529900258468","0.8941176470588236","0.3333333333333333","0.058823529411764705"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile Bernoulli NB classification","0.6005382545174932","UP","6.561529900258468","0.5294117647058824","0.12941176470588237","0.6470588235294118"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile SVC RBF classification","0.5613225682429834","UP","6.561529900258468","0.9","NaN","0.0"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile SVC Tanimoto classification","0.5032679738562094","UP","6.561529900258468","0.8941176470588236","0.0","0.0"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF on folded fp classification","0.49077277970011535","UP","6.561529900258468","0.8823529411764706","0.2","0.058823529411764705"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile SVC Poly classification","0.42714340638216075","UP","6.561529900258468","0.9","NaN","0.0"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF on folded fp classification","0.9089924611603981","UP","8.154901959985743","0.9150197628458498","0.631578947368421","0.4528301886792453"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile Bernoulli NB classification","0.8673205881127889","UP","8.154901959985743","0.5711462450592886","0.19172932330827067","0.9622641509433962"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF classification","0.8666333458286476","UP","8.154901959985743","0.8952569169960475","0.5","0.18867924528301888"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile SVC Tanimoto classification","0.8599483527010696","UP","8.154901959985743","0.9110671936758893","0.7222222222222222","0.24528301886792453"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile SVC RBF classification","0.8109250697655046","UP","8.154901959985743","0.8932806324110671","0.45454545454545453","0.09433962264150944"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile SVC Poly classification","0.8026156857844976","UP","8.154901959985743","0.8972332015810277","0.6666666666666666","0.03773584905660377"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile Bernoulli NB classification","0.8388297872340419","UP","7.68837535480105","0.5480769230769231","0.16363636363636364","0.9"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF on folded fp classification","0.8090425531914893","UP","7.68837535480105","0.9230769230769231","1.0","0.2"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile SVC Tanimoto classification","0.8010638297872336","UP","7.68837535480105","0.9230769230769231","1.0","0.2"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile SVC Poly classification","0.7457446808510638","UP","7.68837535480105","0.9038461538461539","NaN","0.0"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF classification","0.6617021276595745","UP","7.68837535480105","0.8846153846153846","0.0","0.0"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile SVC RBF classification","0.42872340425531913","UP","7.68837535480105","0.8942307692307693","0.0","0.0"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile SVC RBF classification","0.9634408602150537","UP","7.261348494881465","0.941747572815534","1.0","0.4"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.9145161290322579","UP","7.261348494881465","0.9029126213592233","NaN","0.0"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF classification","0.9043010752688172","UP","7.261348494881465","0.9223300970873787","0.6666666666666666","0.4"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF on folded fp classification","0.8887096774193548","UP","7.261348494881465","0.912621359223301","0.5714285714285714","0.4"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile SVC Poly classification","0.88763440860215","UP","7.261348494881465","0.9029126213592233","NaN","0.0"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile Bernoulli NB classification","0.8075268817204301","UP","7.261348494881465","0.6699029126213593","0.18421052631578946","0.7"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile SVC Tanimoto classification","0.9497098646034817","UP","7.3979400086720375","0.8952380952380953","NaN","0.0"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile SVC RBF classification","0.9448742746615086","UP","7.3979400086720375","0.9238095238095239","1.0","0.2727272727272727"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF classification","0.9443907156673114","UP","7.3979400086720375","0.9333333333333333","0.8333333333333334","0.45454545454545453"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile SVC Poly classification","0.9052224371373307","UP","7.3979400086720375","0.8952380952380953","NaN","0.0"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF on folded fp classification","0.8529980657640233","UP","7.3979400086720375","0.9142857142857143","0.6666666666666666","0.36363636363636365"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile Bernoulli NB classification","0.7891682785299805","UP","7.3979400086720375","0.5523809523809524","0.17857142857142858","0.9090909090909091"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF on folded fp classification","0.8331410995770853","UP","6.619070899825681","0.9176470588235294","0.7142857142857143","0.29411764705882354"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile SVC Poly classification","0.771626297577854","UP","6.619070899825681","0.9","NaN","0.0"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF classification","0.7145328719723183","UP","6.619070899825681","0.888235294117647","0.4","0.23529411764705882"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile SVC Tanimoto classification","0.7047289504036911","UP","6.619070899825681","0.9","NaN","0.0"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile Bernoulli NB classification","0.6693579392541328","UP","6.619070899825681","0.45294117647058824","0.1346153846153846","0.8235294117647058"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile SVC RBF classification","0.6620530565167242","UP","6.619070899825681","0.888235294117647","0.0","0.0"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF on folded fp classification","0.8579067990832696","UP","8.049639492796205","0.8947368421052632","0.45454545454545453","0.29411764705882354"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.8374713521772348","UP","8.049639492796205","0.9005847953216374","NaN","0.0"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile SVC Poly classification","0.8367074102368222","UP","8.049639492796205","0.9005847953216374","NaN","0.0"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF classification","0.8296409472880062","UP","8.049639492796205","0.9239766081871345","0.75","0.35294117647058826"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile Bernoulli NB classification","0.8038579067990835","UP","8.049639492796205","0.5263157894736842","0.16666666666666666","0.9411764705882353"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile SVC RBF classification","0.7811306340718085","UP","8.049639492796205","0.9122807017543859","1.0","0.11764705882352941"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF on folded fp classification","0.818041237113402","UP","5.828608177169961","0.9345794392523364","1.0","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile Bernoulli NB classification","0.8103092783505157","UP","5.828608177169961","0.40186915887850466","0.125","0.9"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF classification","0.7907216494845362","UP","5.828608177169961","0.897196261682243","0.3333333333333333","0.1"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC RBF classification","0.780412371134021","UP","5.828608177169961","0.9065420560747663","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Poly classification","0.7773195876288661","UP","5.828608177169961","0.9065420560747663","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Tanimoto classification","0.7298969072164948","UP","5.828608177169961","0.9252336448598131","0.75","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF on folded fp classification","0.818041237113402","UP","5.828608177169961","0.9345794392523364","1.0","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile Bernoulli NB classification","0.8103092783505157","UP","5.828608177169961","0.40186915887850466","0.125","0.9"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF classification","0.7907216494845362","UP","5.828608177169961","0.897196261682243","0.3333333333333333","0.1"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC RBF classification","0.780412371134021","UP","5.828608177169961","0.9065420560747663","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Poly classification","0.7773195876288661","UP","5.828608177169961","0.9065420560747663","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Tanimoto classification","0.7298969072164948","UP","5.828608177169961","0.9252336448598131","0.75","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF on folded fp classification","0.818041237113402","UP","5.828608177169961","0.9345794392523364","1.0","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile Bernoulli NB classification","0.8103092783505157","UP","5.828608177169961","0.40186915887850466","0.125","0.9"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF classification","0.7907216494845362","UP","5.828608177169961","0.897196261682243","0.3333333333333333","0.1"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile SVC RBF classification","0.780412371134021","UP","5.828608177169961","0.9065420560747663","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile SVC Poly classification","0.7773195876288661","UP","5.828608177169961","0.9065420560747663","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile SVC Tanimoto classification","0.7288659793814434","UP","5.828608177169961","0.9252336448598131","0.75","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF on folded fp classification","0.483560794044665","UP","6.269229818221468","0.8978102189781022","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Poly classification","0.4627791563275432","UP","6.269229818221468","0.9051094890510949","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC RBF classification","0.4283498759305207","UP","6.269229818221468","0.8905109489051095","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile Bernoulli NB classification","0.41718362282878413","UP","6.269229818221468","0.26277372262773724","0.08490566037735849","0.6923076923076923"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Tanimoto classification","0.39454094292803993","UP","6.269229818221468","0.8978102189781022","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF classification","0.3678660049627792","UP","6.269229818221468","0.8759124087591241","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF on folded fp classification","0.483560794044665","UP","6.269229818221468","0.8978102189781022","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Poly classification","0.46588089330024807","UP","6.269229818221468","0.9051094890510949","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC RBF classification","0.4283498759305207","UP","6.269229818221468","0.8905109489051095","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Tanimoto classification","0.42369727047146405","UP","6.269229818221468","0.8905109489051095","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile Bernoulli NB classification","0.41718362282878413","UP","6.269229818221468","0.26277372262773724","0.08490566037735849","0.6923076923076923"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF classification","0.3678660049627792","UP","6.269229818221468","0.8759124087591241","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF on folded fp classification","0.483560794044665","UP","6.269229818221468","0.8978102189781022","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile SVC Poly classification","0.4665012406947888","UP","6.269229818221468","0.9051094890510949","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile SVC Tanimoto classification","0.4330024813895781","UP","6.269229818221468","0.8832116788321168","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile SVC RBF classification","0.41780397022332466","UP","6.269229818221468","0.8905109489051095","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile Bernoulli NB classification","0.41718362282878413","UP","6.269229818221468","0.26277372262773724","0.08490566037735849","0.6923076923076923"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF classification","0.3678660049627792","UP","6.269229818221468","0.8759124087591241","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF classification","0.6984797297297297","UP","5.932744106445901","0.8963414634146342","0.42857142857142855","0.1875"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF on folded fp classification","0.6967905405405406","UP","5.932744106445901","0.8780487804878049","0.16666666666666666","0.0625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile Bernoulli NB classification","0.6737753378378375","UP","5.932744106445901","0.22560975609756098","0.08888888888888889","0.75"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Tanimoto classification","0.641258445945946","UP","5.932744106445901","0.8841463414634146","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Poly classification","0.5994510135135136","UP","5.932744106445901","0.9024390243902439","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC RBF classification","0.5895270270270269","UP","5.932744106445901","0.8902439024390244","0.25","0.0625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF classification","0.6984797297297297","UP","5.932744106445901","0.8963414634146342","0.42857142857142855","0.1875"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF on folded fp classification","0.6967905405405406","UP","5.932744106445901","0.8780487804878049","0.16666666666666666","0.0625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile Bernoulli NB classification","0.6737753378378375","UP","5.932744106445901","0.22560975609756098","0.08888888888888889","0.75"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Tanimoto classification","0.6366131756756759","UP","5.932744106445901","0.8841463414634146","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC RBF classification","0.5895270270270269","UP","5.932744106445901","0.8902439024390244","0.25","0.0625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Poly classification","0.5859375000000002","UP","5.932744106445901","0.9024390243902439","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF classification","0.6984797297297297","UP","5.932744106445901","0.8963414634146342","0.42857142857142855","0.1875"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF on folded fp classification","0.6967905405405406","UP","5.932744106445901","0.8780487804878049","0.16666666666666666","0.0625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile Bernoulli NB classification","0.6737753378378375","UP","5.932744106445901","0.22560975609756098","0.08888888888888889","0.75"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile SVC Tanimoto classification","0.6598395270270273","UP","5.932744106445901","0.8841463414634146","0.0","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile SVC RBF classification","0.5891047297297296","UP","5.932744106445901","0.8902439024390244","0.25","0.0625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile SVC Poly classification","0.5888935810810811","UP","5.932744106445901","0.9024390243902439","NaN","0.0"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF on folded fp classification","0.9829545454545454","UP","8.047674563087684","0.9391304347826087","0.7","0.6363636363636364"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF classification","0.9680944055944056","UP","8.047674563087684","0.9217391304347826","0.625","0.45454545454545453"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile SVC Tanimoto classification","0.9580419580419579","UP","8.047674563087684","0.9391304347826087","0.75","0.5454545454545454"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile Bernoulli NB classification","0.9178321678321678","UP","8.047674563087684","0.7130434782608696","0.23809523809523808","0.9090909090909091"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile SVC Poly classification","0.9108391608391608","UP","8.047674563087684","0.8956521739130435","0.3333333333333333","0.09090909090909091"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile SVC RBF classification","0.8190559440559444","UP","8.047674563087684","0.9391304347826087","0.75","0.5454545454545454"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF classification","0.7241935483870967","UP","7.134313596035336","0.8543689320388349","0.0","0.0"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF on folded fp classification","0.6021505376344086","UP","7.134313596035336","0.883495145631068","0.3333333333333333","0.2"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.5612903225806452","UP","7.134313596035336","0.9029126213592233","NaN","0.0"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile SVC Poly classification","0.4526881720430108","UP","7.134313596035336","0.9029126213592233","NaN","0.0"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile SVC RBF classification","0.39139784946236517","UP","7.134313596035336","0.9029126213592233","NaN","0.0"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile Bernoulli NB classification","0.313978494623656","UP","7.134313596035336","0.6504854368932039","0.0","0.0"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF on folded fp classification","0.9160669975186102","UP","9.0","0.9106529209621993","0.631578947368421","0.3870967741935484"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile Bernoulli NB classification","0.9146401985111664","UP","9.0","0.5910652920962199","0.20666666666666667","1.0"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile SVC Tanimoto classification","0.907568238213399","UP","9.0","0.9003436426116839","0.75","0.0967741935483871"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile SVC RBF classification","0.8918114143920591","UP","9.0","0.9106529209621993","0.7272727272727273","0.25806451612903225"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF classification","0.8905086848635236","UP","9.0","0.9243986254295533","0.7142857142857143","0.4838709677419355"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile SVC Poly classification","0.883250620347393","UP","9.0","0.8934707903780069","NaN","0.0"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF classification","0.9582002902757619","UP","8.397940008672037","0.9272727272727272","0.9183673469387755","0.6923076923076923"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile Bernoulli NB classification","0.9476342525399125","UP","8.397940008672037","0.8787878787878788","0.6436781609195402","0.8615384615384616"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF on folded fp classification","0.9431930333817127","UP","8.397940008672037","0.9303030303030303","0.92","0.7076923076923077"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile SVC RBF classification","0.9305370101596523","UP","8.397940008672037","0.9121212121212121","0.95","0.5846153846153846"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile SVC Tanimoto classification","0.9302177068214805","UP","8.397940008672037","0.9363636363636364","0.9583333333333334","0.7076923076923077"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile SVC Poly classification","0.91634252539913","UP","8.397940008672037","0.9363636363636364","0.9782608695652174","0.6923076923076923"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF on folded fp classification","0.9172307692307693","UP","8.050872742805414","0.927536231884058","0.6666666666666666","0.46153846153846156"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF classification","0.907076923076923","UP","8.050872742805414","0.9347826086956522","0.75","0.46153846153846156"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile Bernoulli NB classification","0.8963076923076924","UP","8.050872742805414","0.6521739130434783","0.21311475409836064","1.0"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile SVC RBF classification","0.8886153846153845","UP","8.050872742805414","0.9130434782608695","0.6666666666666666","0.15384615384615385"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile SVC Tanimoto classification","0.828923076923077","UP","8.050872742805414","0.9057971014492754","0.5","0.07692307692307693"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile SVC Poly classification","0.8159999999999983","UP","8.050872742805414","0.9057971014492754","NaN","0.0"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF on folded fp classification","0.5711009174311927","UP","7.880869500874283","0.8512396694214877","0.0","0.0"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile SVC Poly classification","0.5592507645259939","UP","7.880869500874283","0.9008264462809917","NaN","0.0"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile SVC Tanimoto classification","0.5370795107033639","UP","7.880869500874283","0.9008264462809917","NaN","0.0"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile SVC RBF classification","0.44915902140672775","UP","7.880869500874283","0.8925619834710744","0.0","0.0"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF classification","0.3776758409785932","UP","7.880869500874283","0.8677685950413223","0.0","0.0"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile Bernoulli NB classification","0.36582568807339444","UP","7.880869500874283","0.2975206611570248","0.08045977011494253","0.5833333333333334"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF on folded fp classification","0.969066366704162","UP","7.904874861673288","0.9432624113475178","0.8","0.5714285714285714"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile SVC RBF classification","0.9634420697412822","UP","7.904874861673288","0.950354609929078","1.0","0.5"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF classification","0.9609111361079865","UP","7.904874861673288","0.9574468085106383","0.9","0.6428571428571429"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile SVC Tanimoto classification","0.955568053993251","UP","7.904874861673288","0.9290780141843972","0.7","0.5"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile Bernoulli NB classification","0.9403824521934759","UP","7.904874861673288","0.8014184397163121","0.3157894736842105","0.8571428571428571"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile SVC Poly classification","0.9268841394825654","UP","7.904874861673288","0.9432624113475178","1.0","0.42857142857142855"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF on folded fp classification","0.9661234991423671","UP","7.219050533278799","0.9658119658119658","0.8888888888888888","0.7272727272727273"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile SVC Tanimoto classification","0.9429674099485418","UP","7.219050533278799","0.9401709401709402","0.75","0.5454545454545454"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF classification","0.9395368782161234","UP","7.219050533278799","0.9743589743589743","0.9","0.8181818181818182"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile SVC Poly classification","0.9266723842195544","UP","7.219050533278799","0.9145299145299145","1.0","0.09090909090909091"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile Bernoulli NB classification","0.8876500857632947","UP","7.219050533278799","0.8290598290598291","0.3448275862068966","0.9090909090909091"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile SVC RBF classification","0.874785591766725","UP","7.219050533278799","0.9316239316239316","0.8","0.36363636363636365"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile Bernoulli NB classification","0.8178829717291258","UP","7.383173277574704","0.6153846153846154","0.19672131147540983","0.9230769230769231"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF on folded fp classification","0.8165680473372781","UP","7.383173277574704","0.8923076923076924","0.42857142857142855","0.23076923076923078"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF classification","0.8024326101249178","UP","7.383173277574704","0.8923076923076924","0.3333333333333333","0.07692307692307693"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile SVC Poly classification","0.7195923734385273","UP","7.383173277574704","0.9","NaN","0.0"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile SVC Tanimoto classification","0.7051282051282048","UP","7.383173277574704","0.9","NaN","0.0"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile SVC RBF classification","0.5887573964497045","UP","7.383173277574704","0.9","NaN","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF classification","0.6243136582017816","UP","6.0","0.8911678526580159","0.35294117647058826","0.007741935483870968"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile Bernoulli NB classification","0.623309277726192","UP","6.0","0.5462536626203432","0.14583929082070346","0.6580645161290323"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF on folded fp classification","0.615956134684489","UP","6.0","0.8917259662341287","0.0","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile SVC Poly classification","0.6115576930840944","UP","6.0","0.8918654946281568","NaN","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile SVC Tanimoto classification","0.610128689087169","UP","6.0","0.8911678526580159","0.3333333333333333","0.0064516129032258064"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile SVC RBF classification","0.585781521256401","UP","6.0","0.8917259662341287","0.0","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile SVC Tanimoto classification","0.6556042031523684","UP","5.350003492533959","0.8918412003751173","0.35714285714285715","0.007267441860465116"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile SVC Poly classification","0.6491042336985294","UP","5.350003492533959","0.8924663957486715","NaN","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF classification","0.6412359233087624","UP","5.350003492533959","0.891216005001563","0.2777777777777778","0.007267441860465116"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile Bernoulli NB classification","0.6280357797417848","UP","5.350003492533959","0.5548608940293842","0.1472893533638145","0.6555232558139535"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF on folded fp classification","0.6162433052987436","UP","5.350003492533959","0.8923100969052828","0.0","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile SVC RBF classification","0.6082612104427145","UP","5.350003492533959","0.8923100969052828","0.0","0.0"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF classification","0.8065470852017937","UP","7.958607314841775","0.8911290322580645","0.4","0.16"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF on folded fp classification","0.7930941704035874","UP","7.958607314841775","0.9153225806451613","0.6428571428571429","0.36"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile Bernoulli NB classification","0.7804484304932722","UP","7.958607314841775","0.5887096774193549","0.17647058823529413","0.84"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile SVC Poly classification","0.7225112107623316","UP","7.958607314841775","0.8991935483870968","NaN","0.0"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile SVC Tanimoto classification","0.6943497757847525","UP","7.958607314841775","0.9153225806451613","0.75","0.24"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile SVC RBF classification","0.6651121076233187","UP","7.958607314841775","0.8870967741935484","0.2","0.04"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF on folded fp classification","0.8951835767864191","UP","8.522878745280337","0.891566265060241","0.45454545454545453","0.29411764705882354"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF classification","0.8484011054086062","UP","8.522878745280337","0.9036144578313253","0.5555555555555556","0.29411764705882354"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile SVC Poly classification","0.8160284247927364","UP","8.522878745280337","0.8975903614457831","NaN","0.0"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile SVC Tanimoto classification","0.8112909593367544","UP","8.522878745280337","0.8975903614457831","NaN","0.0"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile Bernoulli NB classification","0.8103039873667606","UP","8.522878745280337","0.5240963855421686","0.1702127659574468","0.9411764705882353"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile SVC RBF classification","0.7414133438610347","UP","8.522878745280337","0.9216867469879518","1.0","0.23529411764705882"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF on folded fp classification","0.9563727729556877","UP","8.295968822611028","0.9864253393665159","0.9523809523809523","0.9090909090909091"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF classification","0.9428962996802193","UP","8.295968822611028","0.9728506787330317","0.9","0.8181818181818182"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile SVC Tanimoto classification","0.935815440840567","UP","8.295968822611028","0.9819004524886877","0.9090909090909091","0.9090909090909091"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile SVC Poly classification","0.9248515303791695","UP","8.295968822611028","0.9457013574660633","0.75","0.6818181818181818"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile Bernoulli NB classification","0.9179990863407953","UP","8.295968822611028","0.7420814479638009","0.2727272727272727","0.9545454545454546"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile SVC RBF classification","0.8931018730013714","UP","8.295968822611028","0.9683257918552036","1.0","0.6818181818181818"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF on folded fp classification","0.8871794871794872","UP","7.973591856165454","0.8872180451127819","0.3333333333333333","0.15384615384615385"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF classification","0.8105769230769231","UP","7.973591856165454","0.9022556390977443","0.5","0.3076923076923077"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile Bernoulli NB classification","0.8","UP","7.973591856165454","0.3383458646616541","0.12871287128712872","1.0"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile SVC Poly classification","0.783974358974359","UP","7.973591856165454","0.9022556390977443","NaN","0.0"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile SVC Tanimoto classification","0.7788461538461541","UP","7.973591856165454","0.9022556390977443","0.5","0.15384615384615385"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile SVC RBF classification","0.762820512820513","UP","7.973591856165454","0.924812030075188","0.8","0.3076923076923077"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile SVC Tanimoto classification","0.9002293577981652","UP","7.616243004896307","0.8842975206611571","0.0","0.0"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile Bernoulli NB classification","0.8883792048929663","UP","7.616243004896307","0.6776859504132231","0.23529411764705882","1.0"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF classification","0.8436544342507646","UP","7.616243004896307","0.9090909090909091","0.5714285714285714","0.3333333333333333"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile SVC Poly classification","0.7893730886850157","UP","7.616243004896307","0.9008264462809917","NaN","0.0"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile SVC RBF classification","0.7889908256880739","UP","7.616243004896307","0.9256198347107438","1.0","0.25"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF on folded fp classification","0.7752293577981653","UP","7.616243004896307","0.8842975206611571","0.0","0.0"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF on folded fp classification","0.7268234492160882","UP","5.1682740594863","0.9033149171270718","0.6666666666666666","0.05555555555555555"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF classification","0.7238411724608044","UP","5.1682740594863","0.9116022099447514","0.75","0.16666666666666666"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile SVC Tanimoto classification","0.7003663940013621","UP","5.1682740594863","0.9005524861878453","NaN","0.0"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile SVC RBF classification","0.6898006134969326","UP","5.1682740594863","0.9088397790055248","1.0","0.08333333333333333"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile Bernoulli NB classification","0.6839212678936593","UP","5.1682740594863","0.26243093922651933","0.11627906976744186","0.9722222222222222"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile SVC Poly classification","0.6775306748466271","UP","5.1682740594863","0.9005524861878453","NaN","0.0"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile Bernoulli NB classification","0.7249999999999998","UP","8.201764712727172","0.36065573770491804","0.11627906976744186","0.8333333333333334"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF on folded fp classification","0.7185606060606061","UP","8.201764712727172","0.9016393442622951","0.5","0.16666666666666666"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile SVC Tanimoto classification","0.6613636363636362","UP","8.201764712727172","0.9016393442622951","NaN","0.0"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile SVC RBF classification","0.5621212121212125","UP","8.201764712727172","0.9016393442622951","NaN","0.0"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile SVC Poly classification","0.5553030303030302","UP","8.201764712727172","0.9016393442622951","NaN","0.0"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF classification","0.5458333333333333","UP","8.201764712727172","0.9016393442622951","0.5","0.16666666666666666"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF on folded fp classification","0.9046913580246914","UP","8.149102765287974","0.9133333333333333","0.5833333333333334","0.4666666666666667"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF classification","0.8893827160493828","UP","8.149102765287974","0.9333333333333333","0.8571428571428571","0.4"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile Bernoulli NB classification","0.8553086419753089","UP","8.149102765287974","0.6","0.2","1.0"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile SVC RBF classification","0.846913580246913","UP","8.149102765287974","0.9133333333333333","1.0","0.13333333333333333"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile SVC Tanimoto classification","0.8227160493827159","UP","8.149102765287974","0.9266666666666666","0.75","0.4"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile SVC Poly classification","0.777283950617284","UP","8.149102765287974","0.9","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile SVC RBF classification","0.753990610328639","UP","7.75495799938617","0.9044585987261147","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF classification","0.7241784037558685","UP","7.75495799938617","0.9044585987261147","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile SVC Poly classification","0.7131455399061027","UP","7.75495799938617","0.9044585987261147","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile SVC Tanimoto classification","0.6769953051643194","UP","7.75495799938617","0.9044585987261147","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF on folded fp classification","0.6380281690140845","UP","7.75495799938617","0.9044585987261147","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile Bernoulli NB classification","0.6079812206572767","UP","7.75495799938617","0.5031847133757962","0.12941176470588237","0.7333333333333333"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF classification","0.9079968944099379","UP","8.045757490560675","0.9365853658536586","0.7857142857142857","0.5238095238095238"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF on folded fp classification","0.9017857142857142","UP","8.045757490560675","0.9365853658536586","0.7857142857142857","0.5238095238095238"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile Bernoulli NB classification","0.893633540372671","UP","8.045757490560675","0.6390243902439025","0.21505376344086022","0.9523809523809523"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile SVC Tanimoto classification","0.8535196687370602","UP","8.045757490560675","0.9463414634146341","0.9166666666666666","0.5238095238095238"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile SVC RBF classification","0.8157349896480314","UP","8.045757490560675","0.9170731707317074","0.8333333333333334","0.23809523809523808"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile SVC Poly classification","0.7512939958592129","UP","8.045757490560675","0.926829268292683","0.8","0.38095238095238093"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile Bernoulli NB classification","0.928968253968254","UP","8.096910013008056","0.6495726495726496","0.22641509433962265","1.0"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile SVC Poly classification","0.8841269841269843","UP","8.096910013008056","0.8974358974358975","NaN","0.0"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile SVC Tanimoto classification","0.8817460317460319","UP","8.096910013008056","0.8888888888888888","0.4","0.16666666666666666"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF on folded fp classification","0.8523809523809525","UP","8.096910013008056","0.8803418803418803","0.3333333333333333","0.16666666666666666"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF classification","0.8277777777777777","UP","8.096910013008056","0.8632478632478633","0.0","0.0"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile SVC RBF classification","0.4761904761904763","UP","8.096910013008056","0.8803418803418803","0.0","0.0"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF on folded fp classification","0.9379354182557846","UP","8.698970004336019","0.92018779342723","0.68","0.4927536231884058"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF classification","0.9047673531655226","UP","8.698970004336019","0.9217527386541471","0.7021276595744681","0.4782608695652174"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile Bernoulli NB classification","0.9001017035341946","UP","8.698970004336019","0.7636932707355243","0.30097087378640774","0.8985507246376812"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile SVC Tanimoto classification","0.8998982964657952","UP","8.698970004336019","0.9311424100156495","0.7659574468085106","0.5217391304347826"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile SVC Poly classification","0.8923468090516093","UP","8.698970004336019","0.9029733959311425","1.0","0.10144927536231885"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile SVC RBF classification","0.8280447495550448","UP","8.698970004336019","0.917057902973396","0.75","0.34782608695652173"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF on folded fp classification","0.8245370370370371","UP","6.886056647693163","0.8725490196078431","0.3333333333333333","0.08333333333333333"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF classification","0.8226851851851852","UP","6.886056647693163","0.8627450980392157","0.25","0.08333333333333333"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile SVC Tanimoto classification","0.7703703703703711","UP","6.886056647693163","0.8823529411764706","NaN","0.0"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile SVC Poly classification","0.7472222222222219","UP","6.886056647693163","0.8823529411764706","NaN","0.0"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile Bernoulli NB classification","0.6935185185185189","UP","6.886056647693163","0.7450980392156863","0.26666666666666666","0.6666666666666666"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile SVC RBF classification","0.6462962962962961","UP","6.886056647693163","0.8725490196078431","0.0","0.0"
